ANN ARBOR, Mich. — February 17, 2026 — Leads & Copy — Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) has announced its 2026 production plan has moved from strategy to execution, initiating its multi-ton spider silk scale-up.
The company, a world leader in spider silk technology, has moved bio-material to incubation to get a jumpstart on its March production plan.
This milestone follows Kraig’s recently announced 2026 production schedule, which aims to achieve sustained monthly production of recombinant spider silk cocoons at commercial volumes.
With the release of the first wave of production materials now complete, Kraig Labs has activated its expanded manufacturing pipeline and commenced field-level implementation.
Kraig Labs CEO and Founder Kim Thompson said this is the moment where planning becomes production.
Thompson said that their 2026 roadmap was built around disciplined expansion, operational efficiency, and multi-ton output and is now in motion, with bio-materials recently moved to incubation in preparation for the March production run.
The March production run represents the first major deployment under the Company’s 2026 plan and is designed to drive consistent output, while reinforcing quality control, supply chain stability, and downstream processing capacity.
Kraig Labs said that, by initiating this production cycle, they are delivering on their commitment, creating the world’s first reliable, repeatable, and scalable commercial spider silk manufacturing.
The Company’s vertically integrated model enables rapid deployment of materials, controlled expansion of silkworm rearing operations, and alignment with future customer demand.
Thompson said their focus is on execution, volume, and commercialization, and that every production cycle strengthens their position as the global leader in recombinant spider silk.
Kraig Labs expects this March run to set the pace for subsequent production cycles throughout 2026, forming the foundation for sustained monthly metric-ton-level spider silk production.
Kraig Labs Technology is built on a scientifically engineered silkworm which incorporates key spider silk proteins to produce recombinant spider silk.
For the latest updates on Kraig Labs and its pioneering spider silk technologies, visit www.kraiglabs.com.
For details about recent Kraig Labs advancements, please watch the Company’s investor updates at www.kraiglabs.com/videos or on the Company’s YouTube Channel https://www.youtube.com/@kraigbiocraftlaboratories2270.
To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news
Source: Kraig Biocraft Laboratories, Inc.
